2024 |
Vera Therapeutics Inc - Ordinary Shares - Class A
|
Independent Director |
436.6 K |
- |
2024 |
RayzeBio Inc.
|
Independent Director |
- |
- |
2024 |
Aerovate Therapeutics Inc
|
Independent Director |
- |
- |
2023 |
Aerovate Therapeutics Inc
|
Independent Director |
230.0 K |
51.7 % |
2022 |
Aerovate Therapeutics Inc
|
Independent Director |
151.6 K |
-37.1 % |
2022 |
Vera Therapeutics Inc - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2022 |
RayzeBio Inc.
|
Independent Director |
- |
- |
2021 |
Aerovate Therapeutics Inc
|
Independent Director |
241.1 K |
- |
2021 |
Vera Therapeutics Inc - Ordinary Shares - Class A
|
Independent Director |
96.8 K |
- |
2020 |
Aerovate Therapeutics Inc
|
Independent Director |
- |
- |
2020 |
Vera Therapeutics Inc - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2017 |
Apellis Pharmaceuticals Inc
|
Director |
- |
- |
2016 |
Apellis Pharmaceuticals Inc
|
Director |
- |
- |